| Literature DB >> 19812771 |
Kanaka Durga Kedarisetti1, Scott Dick, Lukasz Kurgan.
Abstract
The exact mechanisms of prion misfolding and factors that predispose an individual to prion diseases are largely unknown. Our approach to identifying candidate factors in-silico relies on contrasting the C-terminal domain of PrP(C) sequences from two groups of vertebrate species: those that have been found to suffer from prion diseases, and those that have not. We propose that any significant differences between the two groups are candidate factors that may predispose individuals to develop prion disease, which should be further analyzed by wet-lab investigations. Using an array of computational methods we identified possible point mutations that could predispose PrP(C) to misfold into PrP(Sc). Our results include confirmatory findings such as the V210I mutation, and new findings including P137M, G142D, G142N, D144P, K185T, V189I, H187Y and T191P mutations, which could impact structural stability. We also propose new hypotheses that give insights into the stability of helix-2 and -3. These include destabilizing effects of Histidine and T188-T193 segment in helix-2 in the disease-prone prions, and a stabilizing effect of Leucine on helix-3 in the disease-resistant prions.Entities:
Keywords: conformational transition; exchange groups; point mutations; prion misfolding; prions; sequence alignment
Year: 2008 PMID: 19812771 PMCID: PMC2735959 DOI: 10.4137/bbi.s550
Source DB: PubMed Journal: Bioinform Biol Insights ISSN: 1177-9322
Figure 1Sequence and mutations in the C-terminal domain of huPrP together with the ribbon drawing of the corresponding 3D structure (positions 125 to 228 of 1HJM). The secondary structure segments are denoted by underscores. Bold indicates pathogenic mutations associated with the CJD phenotype, underline indicates GSS, and italic indicates FFI.
List of physicochemical amino acid indices and chemical groups used to derive features.
| Amino acid | Code | Index | Physicochemical index/chemical groups
| ||||
|---|---|---|---|---|---|---|---|
| Associated chemical groups | |||||||
| Alanine | A | 1 | 71.0791 | 6.01 | 0.42 | 0.62 | CH CO NH CH3 |
| Cysteine | C | 2 | 103.1437 | 5.07 | 1.34 | 0.29 | CH CO NH CH2 SH |
| Aspartate | D | 3 | 115.0887 | 2.77 | −1.05 | −0.9 | CH CO NH CH2 CO COO− |
| Glutamate | E | 4 | 129.1157 | 3.22 | −0.87 | −0.74 | CH CO NH CH2 CH2 CO COO− |
| Phenylalanine | F | 5 | 147.1772 | 5.48 | 2.44 | 1.19 | CH CO NH CH2 CAROM
|
| Glycine | G | 6 | 57.0521 | 5.97 | 0 | 0.48 | CH2 CO NH |
| Histidine | H | 7 | 137.1414 | 7.59 | 0.18 | −0.4 | CH CO NH CH2 CAROM
|
| Isoleucine | I | 8 | 113.16 | 6.02 | 2.46 | 1.38 | CH CO NH CH2 CH CH3 CH3 |
| Lysine | K | 9 | 128.1792 | 9.74 | −1.35 | −1.5 | CH CO NH CH2 CH2 CH2 |
| Leucine | L | 10 | 113.16 | 5.98 | 2.32 | 1.06 | CH CO NH CH2 CH CH3 CH3 |
| Methionine | M | 11 | 131.1977 | 5.47 | 1.68 | 0.64 | CH CO NH CH2 CH2 S CH3 |
| Asparagine | N | 12 | 114.104 | 5.41 | −0.82 | −0.78 | CH CO NH CH2 CO C NH2 |
| Proline | P | 13 | 97.1171 | 6.48 | 0.98 | 0.12 | CHRING CO NHRING CH2RING
|
| Glutamine | Q | 14 | 128.131 | 5.65 | −0.3 | −0.85 | CH CO NH CH2 CH2 CO C NH2 |
| Arginine | R | 15 | 156.188 | 10.76 | −1.37 | −2.53 | CH CO NH CH2 CH2 CH2 NH C
|
| Serine | S | 16 | 87.0784 | 5.68 | −0.05 | −0.18 | CH CO NH CH2 OH |
| Threonine | T | 17 | 101.1054 | 5.87 | 0.35 | −0.05 | CH CO NH CH CH3 OH |
| Valine | V | 18 | 99.133 | 5.97 | 1.66 | 1.08 | CH CO NH CH CH3 CH3 |
| Tryptophan | W | 19 | 186.2139 | 5.89 | 3.07 | 0.81 | CH CO NH CH2 CAROM
|
| Tyrosine | Y | 20 | 163.1756 | 5.67 | 1.31 | 0.26 | CH CO NH CH2 CAROM
|
Property groups of amino acids used to derive features.
| Groups | Subgroups | AAs | Groups | Subgroups | AAs |
|---|---|---|---|---|---|
| R groups | Nonpolar aliphatic | AVLIMG | Hydrophobicity groups | Hydrophobic | VLIMAFPWYCG |
| Polar uncharged | SPTCNQ | Hydrophilic basic | KHR | ||
| Positively charged | KHR | Hydrophilic acidic | DE | ||
| Negative | DE | Hydrophilic polar with uncharged side chain | STNQ | ||
| Aromatic | FYW | ||||
| Exchange groups | E1 | KHR | Electronic groups | Electron donor | DEPA |
| E2 | DENQ | Weak electron donor | VLI | ||
| E3 | C | Electron acceptor | KNR | ||
| E4 | AGPST | Weak electron acceptor | FYMTQ | ||
| E5 | ILMV | Neutral | GHWS | ||
| E6 | FYW | Special AA | C | ||
| Other groups | Charged | DEKHRVLI | Other groups | Tiny | AG |
| Polar | DEKHRNTQSYW | Bulky | FHWYR | ||
| Aromatic | FHWY | Polar-uncharged | NQ | ||
| Small | AGST |
Figure 2Results of sequence alignment between the three PD-resistant prions (top) and the eight PD-prone prions (identified by the PDB ID for the protein).
aPositions are encoded with respect to the huPrP.
b“Conservation” line shows positions (black squares with the corresponding residues shown in bold) that were significant based on the conservation of amino acids.
c“Exch. group” line shows positions (black squares with the corresponding residues underlined) that were significant based on the conservation of amino acids grouped in exchange groups.
d“Feature sel.” line shows positions (black squares with the corresponding residues denoted by dotted line boxes) that were significant based on the feature selection.
Top five features that differentiate between PD-prone and resistant prions.
| Feature | Avg. rank | Bi-serial correlation coefficient |
|---|---|---|
| 7.6 | 0.97 | |
| Chemical N group | 9.3 | 0.94 |
| 11.1 | 0.97 | |
| 12.2 | 0.96 | |
| 12.8 | 0.99 |
Figure 3Values of top five features for the 11 prion sequences: features that indicate abundance of the associated amino acids in A) PD-prone prions, and B) PD-resistant prions. The first three sequences correspond to the PD-resistant prions, and the remaining sequences to the PD-prone prions.